← Back to Research Radar
Academic Publication Academic Publication

Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

133
Citations
August 1, 2024
Published Date

Research Abstract & Technology Focus

No abstract provided for this literature.
efficacy safety inhibitors without glucagon-like peptide
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org ā€ŗ academic paper
100%
šŸ”„

Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

No description provided.
crossref.org ā€ŗ academic paper
0%

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

BACKGROUND: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) consistently improve heart failure and kidney-related outcomes; however, effects on major adverse cardiovascular events (M...
crossref.org ā€ŗ academic paper
0%

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy

AbstractThe glucagon-like peptide-1 (GLP-1) receptor, known as GLP-1R, is a vital component of the G protein-coupled receptor (GPCR) family and is found primarily on the surfaces of various cell ty...
crossref.org ā€ŗ academic paper
0%

Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or ...
crossref.org ā€ŗ academic paper
0%

Changes in lean body mass with glucagonā€like peptide ā€1ā€based therapies and mitigation strategies

Abstract Weight loss induced by glucagonā€like peptideā€1 receptor agonists (GLPā€1RAs) and dual glucagonā€like peptideā€1 receptor (GLPā€1R)/glucoseā€dependent insulinotropic polypeptid...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials'?

This literature focuses on:

Are there open-source GitHub repositories related to Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials?

Yes, open-source projects like jherrodthomas/automotive-skills-suite (100+ installable Claude skills covering Engineering areas such as, ISO 26262 functional safety, ISO/SAE 21434 cybersecurity, ISO 21448 SOTIF, AIAG-...) are actively building upon these concepts.

Which startups are commercializing the technology behind Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials?

Products like ElevenAgents Guardrails 2.0 are bringing this to market. Their focus is: Configurable safety control for enterprise agent deployment..

What other academic literature is closely related to 'Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials'?

Yes, highly correlated activity was mapped. An entry titled 'Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials' discusses this: No description provided.

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Associated Media Narrative